Zobrazeno 1 - 10
of 50
pro vyhledávání: '"FEI-RAN GONG"'
Autor:
Yin-Ling Wang, Xin-Xin Ge, Yi Wang, Meng-Dan Xu, Fei-Ran Gong, Min Tao, Wen-Jie Wang, Liu-Mei Shou, Kai Chen, Meng-Yao Wu, Wei Li
Publikováno v:
BMC Gastroenterology, Vol 18, Iss 1, Pp 1-12 (2018)
Abstract Background The classifications and counts of white blood cells (WBCs) have been proved to be able to be used as prognostic markers in cancer cases. The present study investigated the potential values of the classifications and counts of WBC,
Externí odkaz:
https://doaj.org/article/a424d1d6f0cd496cbde6d1b5b744f6af
Autor:
Meng Shen, Meng-Yao Wu, Long-Pei Chen, Qiaoming Zhi, Fei-Ran Gong, Kai Chen, Dao-Ming Li, Yadi Wu, Min Tao, Wei Li
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-2 (2021)
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Externí odkaz:
https://doaj.org/article/1a90abf55e244957a4908c80547e71a8
Autor:
Long-Pei Chen, Yadi Wu, Wei Li, Min Tao, Kai Chen, Dao-Ming Li, Fei-Ran Gong, Meng Shen, Qiaoming Zhi, Meng-Yao Wu
Publikováno v:
Scientific Reports
Scientific Reports, Vol 11, Iss 1, Pp 1-2 (2021)
Scientific Reports, Vol 11, Iss 1, Pp 1-2 (2021)
Cantharidin is an active constituent of mylabris, a traditional Chinese medicine, and is a potent and selective inhibitor of protein phosphatase 2A (PP2A) that plays an important role in cell cycle control, apoptosis, and cell-fate determination. In
Autor:
Shu-Ling Liu, Wei Li, Bei-Bei Zheng, Jing Wu, Junning Zhang, Yan Zhang, Meng-Dan Xu, Meng-Yao Wu, Fei-Ran Gong, Min Tao
Publikováno v:
Pancreatology. 18:822-832
Background Cantharidin is an inhibitor of protein phosphatase 2 A (PP2A), and has been frequently used in clinical practice. In our previous study, we proved that cantharidin could arrest cell cycle in G2/M phase. Since cells at G2/M phase are sensit
Autor:
Fei-Ran Gong, Kai Chen, Meng-Yao Wu, Min Tao, Yi Wang, Liu-Mei Shou, Meng-Dan Xu, Yin-Ling Wang, Xin-Xin Ge, Wenjie Wang, Wei Li
Publikováno v:
BMC Gastroenterology, Vol 18, Iss 1, Pp 1-12 (2018)
BMC Gastroenterology
BMC Gastroenterology
Background The classifications and counts of white blood cells (WBCs) have been proved to be able to be used as prognostic markers in cancer cases. The present study investigated the potential values of the classifications and counts of WBC, includin
Autor:
Liu Lu, Wei Li, Yan Zhang, Meng-Yao Wu, Bairong Shen, Meng Shen, Jie Yu, Fei-Ran Gong, Yuan Gao, Min Tao, Meng-Dan Xu, Jin Zhou, Yu-Chen Tang, Dong-Mei Gu, Qiaoming Zhi
Publikováno v:
International Journal of Oncology
Anti-angiogenic therapy has been successfully applied to treat colorectal cancer (CRC). Ginsenoside Rg3, derived from the Chinese herb ginseng, has anti-vascularization effects and can inhibit tumor growth and metastasis, and can sensitize cancer cel
Autor:
Yuan Gao, Wenjie Wang, Meng-Yao Wu, Meng Shen, Wei Li, Xiaojie Bian, Min Tao, Lian Lian, Fei-Ran Gong, Min Jiang, Jun Feng, Chong Zhou, Qiaoming Zhi
Publikováno v:
Oncotarget
// Yuan Gao 1, * , Wen-Jie Wang 1, * , Qiaoming Zhi 2, * , Meng Shen 1 , Min Jiang 1 , Xiaojie Bian 1 , Fei-Ran Gong 3 , Chong Zhou 4 , Lian Lian 1, 5 , Meng-Yao Wu 1 , Jun Feng 1 , Min Tao 1, 6 and Wei Li 1, 6, 7 1 Department of Oncology, The First
Autor:
Junning Zhang, Wei-Ming Duan, Meng Shen, Jie Yu, Zeyi Liu, Fei-Ran Gong, Shu-Ling Liu, Liu-Mei Shou, Min Tao, Yi-Zhong Feng, Wei Li, Meng-Dan Xu, Meng-Yao Wu, Dong-Mei Gu, Kai Chen, Qiang Liu, Qi Zhu, Qiaoming Zhi
Publikováno v:
Oncotarget
Squamous cell carcinoma (SCC) of pancreas is a rare histotype of pancreatic ductal carcinoma which is distinct from pancreatic adenocarcinoma (AC). Although there are standard treatments for pancreatic AC, no precise therapies exist for pancreatic SC
Autor:
Wei Li, Min Tao, Fei‑Ran Gong, Xin‑Xin Ge, Meng‑Yao Wu, Jing Wu, Meng‑Dan Xu, Lian Lian, Wenjie Wang, Weihua Qian
Publikováno v:
Oncology Letters
Colorectal cancer (CRC) represents the third most common malignancy worldwide. The aim of the present study was to investigate the predictive values of platelet-associated indicators, including platelet count (PLT), plateletcrit (PCT), mean platelet
Autor:
Wei-Ming Duan, Xin‑Xin Ge, Meng‑Dan Xu, Kai Chen, Meng‑Yao Wu, Wenyu Zhu, Min Tao, Wenjie Wang, Qiaoming Zhi, Fei‑Ran Gong, Jing Wu, Liu‑Mei Shou
Publikováno v:
Molecular Medicine Reports.
The count and classification of white blood cells (WBCs) may be used as prognostic markers in certain types of cancer. The present study investigated the prognostic potential of the counts of WBCs, including lymphocytes (LYs), monocytes (MOs), neutro